Current concepts in the management of idiopathic sudden sensorineural hearing loss

Brendan P. O'Connell, Jacob B. Hunter, David S. Haynes

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Purpose of review The purpose of this manuscript is to review the initial management strategies for idiopathic sudden sensorineural hearing loss, with an emphasis on the role that steroids play in treatment of this condition, and discuss options for auditory rehabilitation of persistent unilateral hearing loss. Recent findings Recent data suggest that hearing improvement may be greater for patients initially treated with both systemic and intratympanic steroid when compared with those treated with systemic steroids alone. Salvage intratympanic steroids have been shown to confer hearing benefit if initial management fails. The ideal dosing regimen for intratympanic steroids has not been established, but evidence supports that higher dosing strategies are advantageous. Cochlear implantation has emerged as a strategy for auditory rehabilitation of persistent unilateral hearing loss. Recent studies have demonstrated high patient satisfaction, subjective improvement in tinnitus, and objective performance benefit after cochlear implantation for single-sided deafness. Summary Patients can be offered steroid therapy in the initial management of idiopathic sudden sensorineural hearing loss, but should be counseled that the efficacy of steroids remains unclear. If patients fail to improve with initial management, salvage intratympanic steroid administration should be considered. If hearing loss persists long term, options for auditory rehabilitation should be discussed.

Original languageEnglish (US)
Pages (from-to)413-419
Number of pages7
JournalCurrent Opinion in Otolaryngology and Head and Neck Surgery
Volume24
Issue number5
DOIs
StatePublished - Jan 1 2016

Fingerprint

Sudden Hearing Loss
Sensorineural Hearing Loss
Steroids
Unilateral Hearing Loss
Cochlear Implantation
Rehabilitation
Hearing
Tinnitus
Deafness
Patient Satisfaction
Hearing Loss

Keywords

  • Bone-anchored implants
  • Cochlear implant
  • Hearing rehabilitation
  • Steroids
  • Sudden sensorineural hearing loss

ASJC Scopus subject areas

  • Surgery
  • Otorhinolaryngology

Cite this

Current concepts in the management of idiopathic sudden sensorineural hearing loss. / O'Connell, Brendan P.; Hunter, Jacob B.; Haynes, David S.

In: Current Opinion in Otolaryngology and Head and Neck Surgery, Vol. 24, No. 5, 01.01.2016, p. 413-419.

Research output: Contribution to journalReview article

@article{18f141b31cd440d585898b43119ec86b,
title = "Current concepts in the management of idiopathic sudden sensorineural hearing loss",
abstract = "Purpose of review The purpose of this manuscript is to review the initial management strategies for idiopathic sudden sensorineural hearing loss, with an emphasis on the role that steroids play in treatment of this condition, and discuss options for auditory rehabilitation of persistent unilateral hearing loss. Recent findings Recent data suggest that hearing improvement may be greater for patients initially treated with both systemic and intratympanic steroid when compared with those treated with systemic steroids alone. Salvage intratympanic steroids have been shown to confer hearing benefit if initial management fails. The ideal dosing regimen for intratympanic steroids has not been established, but evidence supports that higher dosing strategies are advantageous. Cochlear implantation has emerged as a strategy for auditory rehabilitation of persistent unilateral hearing loss. Recent studies have demonstrated high patient satisfaction, subjective improvement in tinnitus, and objective performance benefit after cochlear implantation for single-sided deafness. Summary Patients can be offered steroid therapy in the initial management of idiopathic sudden sensorineural hearing loss, but should be counseled that the efficacy of steroids remains unclear. If patients fail to improve with initial management, salvage intratympanic steroid administration should be considered. If hearing loss persists long term, options for auditory rehabilitation should be discussed.",
keywords = "Bone-anchored implants, Cochlear implant, Hearing rehabilitation, Steroids, Sudden sensorineural hearing loss",
author = "O'Connell, {Brendan P.} and Hunter, {Jacob B.} and Haynes, {David S.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1097/MOO.0000000000000289",
language = "English (US)",
volume = "24",
pages = "413--419",
journal = "Current Opinion in Otolaryngology and Head and Neck Surgery",
issn = "1068-9508",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Current concepts in the management of idiopathic sudden sensorineural hearing loss

AU - O'Connell, Brendan P.

AU - Hunter, Jacob B.

AU - Haynes, David S.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Purpose of review The purpose of this manuscript is to review the initial management strategies for idiopathic sudden sensorineural hearing loss, with an emphasis on the role that steroids play in treatment of this condition, and discuss options for auditory rehabilitation of persistent unilateral hearing loss. Recent findings Recent data suggest that hearing improvement may be greater for patients initially treated with both systemic and intratympanic steroid when compared with those treated with systemic steroids alone. Salvage intratympanic steroids have been shown to confer hearing benefit if initial management fails. The ideal dosing regimen for intratympanic steroids has not been established, but evidence supports that higher dosing strategies are advantageous. Cochlear implantation has emerged as a strategy for auditory rehabilitation of persistent unilateral hearing loss. Recent studies have demonstrated high patient satisfaction, subjective improvement in tinnitus, and objective performance benefit after cochlear implantation for single-sided deafness. Summary Patients can be offered steroid therapy in the initial management of idiopathic sudden sensorineural hearing loss, but should be counseled that the efficacy of steroids remains unclear. If patients fail to improve with initial management, salvage intratympanic steroid administration should be considered. If hearing loss persists long term, options for auditory rehabilitation should be discussed.

AB - Purpose of review The purpose of this manuscript is to review the initial management strategies for idiopathic sudden sensorineural hearing loss, with an emphasis on the role that steroids play in treatment of this condition, and discuss options for auditory rehabilitation of persistent unilateral hearing loss. Recent findings Recent data suggest that hearing improvement may be greater for patients initially treated with both systemic and intratympanic steroid when compared with those treated with systemic steroids alone. Salvage intratympanic steroids have been shown to confer hearing benefit if initial management fails. The ideal dosing regimen for intratympanic steroids has not been established, but evidence supports that higher dosing strategies are advantageous. Cochlear implantation has emerged as a strategy for auditory rehabilitation of persistent unilateral hearing loss. Recent studies have demonstrated high patient satisfaction, subjective improvement in tinnitus, and objective performance benefit after cochlear implantation for single-sided deafness. Summary Patients can be offered steroid therapy in the initial management of idiopathic sudden sensorineural hearing loss, but should be counseled that the efficacy of steroids remains unclear. If patients fail to improve with initial management, salvage intratympanic steroid administration should be considered. If hearing loss persists long term, options for auditory rehabilitation should be discussed.

KW - Bone-anchored implants

KW - Cochlear implant

KW - Hearing rehabilitation

KW - Steroids

KW - Sudden sensorineural hearing loss

UR - http://www.scopus.com/inward/record.url?scp=84976328189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976328189&partnerID=8YFLogxK

U2 - 10.1097/MOO.0000000000000289

DO - 10.1097/MOO.0000000000000289

M3 - Review article

C2 - 27348351

AN - SCOPUS:84976328189

VL - 24

SP - 413

EP - 419

JO - Current Opinion in Otolaryngology and Head and Neck Surgery

JF - Current Opinion in Otolaryngology and Head and Neck Surgery

SN - 1068-9508

IS - 5

ER -